Navigation Links
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Date:6/22/2013

p>® pen is the winner of a number of innovative design awards including the Red Dot Award, the Good Design Award, and the iF Product Design Award. 

About Sanofi Diabetes
Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices including blood glucose monitoring systems. Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes.

About Sanofi
Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US, also referred to as sanofi-aventis U.S. LLC. For more information on Sanofi US, please visit http://www.sanofi.us or call 1-800-981-2491.

Forward Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and st
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or ... development, marketing and distribution of opioid-related immunotherapies, announced ... with the Securities and Exchange Commission in connection ... be held on Thursday, September 4, 2014, at ... for determining those shareholders eligible to receive notice ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... Minn. , July 28, 2014  ANI Pharmaceuticals, ... the Company plans to release its second quarter and ... before the opening of the U.S. financial markets. The ... Relations section of the Company,s website, www.anipharmaceuticals.com . ... Chief Executive Officer, and Charlotte C. Arnold , ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... Ticketability.com has reduced the cost of Phantom of ... lower prices on the secure website. Customers are invited to ... tickets that are priced lower every day. , Click ... Ticketability.com. , Theatergoers know that attending an entertaining show can ... the Opera tickets for sale that are priced to fit ...
(Date:7/28/2014)... Treat skin to a true cleansing with the ... and tomorrow only (while supplies last), take 40% off at ... for two specific users: , 1) those with oily skin ... and , 2) aging skin to help reduce lines, exfoliate ... of Sublime Beauty®. , Those with oily skin can use ...
(Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:7/28/2014)... La Mirada, CA (PRWEB) July 28, 2014 ... anyone seeking to pilot an airplane, helicopter, gyroplan or ... training. Those hoping to pilot balloons and gliders are ... purpose of the physical exam is to alert potential ... or prevent safe aviation. By detecting these conditions early, ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook to ... Surgical Generators market. The report provides value, in ... average prices (in US dollars) within market segments ... Argon Plasma Coagulation Generators. , The report also ... each of these market categories, and global corporate-level ...
Breaking Medicine News(10 mins):Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Healthpointe Invites All Aspiring Pilots to Complete an FAA Certified Exam 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4
... SEATTLE, Aug. 5 On Thursday, August 6, 2009, ... Cell Therapeutics, Inc.,s (CTI) (Nasdaq and MTA: CTIC) management team will ... financial results. , , ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, ...
... , , ... , SILVER SPRING, Md., Aug. 5 For ... an Obesity Medicine Physician Certification (OMPC) Examination. The 18-month process of ... with an expected completion in March 2010. According to Dr. Robert ...
... , SAN FRANCISCO, Aug. 4 More ... Francisco Wednesday to protest gaps by California hospitals in safety preparation ... announced today. , , The nurses ... blew the whistle on unsafe patient care involving swine flu at ...
... , , ... ViroPharma Incorporated (Nasdaq: VPHM ... Committee supports the FDA,s Office of Generic Drugs (OGD) draft guidelines ... used to treat severe, often life-threatening bacterial infections of the gastrointestinal ...
... , , WASHINGTON, Aug. ... announced financial results for the first quarter of its fiscal year ending ... to $57.2 million in the first quarter of fiscal 2009. Net ... million, or $0.36 per diluted share, for the same period a year ...
... , EAST RUTHERFORD, N.J., Aug. 4 Cambrex Corporation ... 30, 2009. , , Highlights , , ... impact of foreign currency. Reported sales declined by 9.8% for the quarter. , ... in the same quarter last year (see attached table). , ...
Cached Medicine News:Health News:Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 2Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 10Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 11Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 12Health News:Cambrex Reports Second Quarter 2009 Results 2Health News:Cambrex Reports Second Quarter 2009 Results 3Health News:Cambrex Reports Second Quarter 2009 Results 4Health News:Cambrex Reports Second Quarter 2009 Results 5Health News:Cambrex Reports Second Quarter 2009 Results 6Health News:Cambrex Reports Second Quarter 2009 Results 7Health News:Cambrex Reports Second Quarter 2009 Results 8Health News:Cambrex Reports Second Quarter 2009 Results 9Health News:Cambrex Reports Second Quarter 2009 Results 10Health News:Cambrex Reports Second Quarter 2009 Results 11Health News:Cambrex Reports Second Quarter 2009 Results 12
... consisting of 38 cobbs, osteotomes, elevators, ... spine. The instruments extra (15) length ... best applied in thoracic, lumbar and ... for surgeons to pick and choose ...
... growth factors (AGF) technology. Using ... AGF gel delivers a cocktail ... and proteins in high concentrations ... of new bone cells and ...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution....
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: